论文部分内容阅读
有关肿瘤标记物用来观察抗癌疗效的论文稀少文中报告1例肾盂癌,血中及癌细胞中CA·19-9值增高,且随治疗后癌的变化而波动。患者男,64岁,持续发热一月入院。CT诊断:左肾盂癌、肾门淋巴结转移。血CA19-19值2200u/ml。行左肾盂癌根治术。病理诊断:肾盂输尿管移行上皮癌,癌细胞CA19-9染色阳性。术后CA19-9值测定降至67u/ml。二月后加用局部放疗,三月后胸片检查发现肺部多发性肿瘤转移,血CA19-9值为96u/ml。即行M-VAC化疗,肺转移灶消失,但行CT复查见手术局部肿瘤复发,血
Tumor markers have been used to observe the efficacy of anticancer drugs in rare papers reported in 1 case of renal pelvis cancer, CA19-9 value in blood and cancer cells increased, and with the treatment of changes in cancer and fluctuations. The patient male, 64 years old, continued to have fever and was admitted to the hospital in January. CT diagnosis: left renal pelvis cancer, renal lymph node metastasis. Blood CA19-19 value 2200u/ml. Left renal pelvic cancer radical surgery. Pathological diagnosis: renal pelvis and ureter transitional epithelial cancer, cancer cell CA19-9 staining positive. After the determination of CA19-9 value was reduced to 67u/ml. Local radiotherapy was added after February, and chest radiographs showed metastasis of multiple tumors in the lung in March. The blood CA19-9 value was 96 u/ml. When M-VAC chemotherapy was performed, the lung metastases disappeared, but the recurrence of local tumor recurrence and blood were seen during the CT scan.